Canada • TSX Venture Exchange • TSX-V:HITI • CA42981E4013
Taking everything into account, HITI scores 4 out of 10 in our fundamental rating. HITI was compared to 34 industry peers in the Pharmaceuticals industry. The financial health of HITI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, HITI is valued expensive at the moment.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 4.61% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 2.89 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.8 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.46 | ||
| EV/EBITDA | 8.37 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 4 / 10 to HITI.CA.
ChartMill assigns a valuation rating of 3 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Overvalued.
HIGH TIDE INC (HITI.CA) has a profitability rating of 3 / 10.
The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to grow by 3.81% in the next year.